How to Get Armour Thyroid in Mississippi

At a glance
- Drug / Armour Thyroid (natural desiccated thyroid, porcine-derived)
- Manufacturer / AbbVie/Allergan
- Prescription status / Prescription-only in Mississippi
- Telehealth prescribing / Permitted under Mississippi telehealth law
- Compounding option / 503A compounding pharmacies licensed in MS may dispense NDT
- Mississippi Medicaid coverage / Not covered for hypothyroidism
- Starting dose range / 30 mg (0.5 grain) to 60 mg (1 grain) daily, titrated on TSH/FT3/FT4
- Key labs before starting / TSH, Free T4, Free T3, TPO antibodies
- Time to first fill / Typically 3 to 14 days from initial consultation
- Who can prescribe / MD, DO, NP (with prescriptive authority), PA (with prescriptive authority)
What Armour Thyroid Actually Is
Armour Thyroid is a prescription tablet made from desiccated porcine thyroid gland. Each grain (60 mg) contains approximately 38 mcg of thyroxine (T4) and 9 mcg of triiodothyronine (T3), giving it a fixed T4:T3 ratio of roughly 4:1 [1]. That ratio differs from the 14:1 or higher ratio typical of human thyroid secretion, which is one reason dosing requires careful titration.
The FDA reviewed Armour Thyroid under its pre-1962 grandfather status, meaning the product was marketed before the modern New Drug Application process. The current prescribing information is maintained by AbbVie and available through the FDA's online label database [2]. Armour Thyroid is indicated for hypothyroidism, as adjunctive therapy in pituitary TSH suppression, and for thyroid-stimulating hormone suppression in thyroid cancer.
Patients sometimes prefer Armour Thyroid over levothyroxine monotherapy because the added T3 may relieve residual symptoms such as fatigue and cognitive difficulty that persist despite normal TSH. Hoang et al. (J Clin Endocrinol Metab, 2013; N=70) found that 49% of participants preferred desiccated thyroid extract over levothyroxine after a blinded crossover, with patients on desiccated thyroid losing an average of 0.9 kg more than those on levothyroxine (P<0.001) [3]. That is a relatively small trial, and the result has not been replicated at scale, so preference data should be interpreted carefully.
Mississippi Prescribing Law and Who Can Write the Prescription
Any fully licensed Mississippi clinician with prescriptive authority may write an Armour Thyroid prescription. That group includes:
- MDs and DOs licensed by the Mississippi State Board of Medical Licensure.
- Nurse practitioners holding a Certificate of Prescriptive Authority under the Mississippi Board of Nursing. Mississippi NPs with a CPA may prescribe Schedule II through V controlled substances and all non-controlled medications without a standing physician agreement as of 2023.
- Physician assistants licensed by the Mississippi State Board of Medical Licensure; PAs in Mississippi practice under a supervision agreement but hold independent prescriptive authority for non-controlled drugs.
No special DEA registration is needed for Armour Thyroid because it is not a controlled substance. A clinician who is willing to prescribe natural desiccated thyroid (NDT) is the only gating requirement from a legal standpoint.
The challenge is clinical, not regulatory. Many endocrinologists and primary care physicians in Mississippi default to levothyraxine because the American Thyroid Association's 2014 guidelines concluded that "there is insufficient evidence to recommend" desiccated thyroid extract as first-line therapy [4]. Patients who want Armour Thyroid may need to specifically ask, provide a prior prescription history, or seek a clinician who practices integrative or functional medicine.
Getting an Armour Thyroid Prescription Through Telehealth in Mississippi
Mississippi is a full telehealth prescribing state. The Mississippi Telemedicine Act (Miss. Code Ann. § 83-9-351) requires that a valid patient-provider relationship exist before a prescription is issued, but that relationship can be established through a synchronous audio-video visit. No prior in-person encounter is required for non-controlled medications.
A typical telehealth pathway for Armour Thyroid in Mississippi looks like this:
Step 1. Lab work first. Order TSH, Free T4, Free T3, and TPO antibodies before your visit. Many telehealth platforms let you order these at a local Quest or LabCorp draw site for under $100 out-of-pocket. Having results in hand before your appointment shortens the consultation and allows the clinician to prescribe at the visit rather than after a follow-up.
Step 2. Synchronous video consultation. During a 20 to 40 minute video visit, the clinician reviews your symptom history, lab values, and any prior thyroid prescriptions. Bring a list of all current medications because Armour Thyroid has clinically relevant interactions with calcium, iron supplements, antacids, and certain cholesterol medications.
Step 3. Electronic prescription. If the clinician decides Armour Thyroid is appropriate, the e-prescription goes directly to your chosen Mississippi pharmacy. Armour Thyroid is not a controlled substance, so no paper prescription or "wet signature" is required under Mississippi law.
Step 4. Follow-up labs at 6 to 8 weeks. Most clinicians recheck TSH and Free T3 six to eight weeks after any dose change. Given the T3 component, TSH alone may not capture the full hormonal picture, and a suppressed TSH with normal Free T3 requires clinical interpretation rather than automatic dose reduction.
HealthRX clinicians licensed in Mississippi conduct these visits and can send prescriptions to the retail or compounding pharmacy of your choice.
Labs Required Before Starting Armour Thyroid in Mississippi
No Mississippi-specific statute mandates a particular lab panel before prescribing Armour Thyroid, but responsible prescribing standards drawn from endocrine society guidance expect the following at minimum:
TSH (thyrotropin). The single most sensitive marker for thyroid axis function. The American Association of Clinical Endocrinology considers a TSH between 0.45 and 4.12 mIU/L the standard reference range, though some functional medicine clinicians use a narrower 1.0 to 2.5 mIU/L target for symptom-based management [5].
Free T4 and Free T3. Because Armour Thyroid supplies both hormones, baseline free levels matter. A patient with low-normal Free T3 despite normal TSH may be a better candidate for combination therapy than a patient whose Free T3 is already in the upper third of range.
TPO antibodies (anti-thyroid peroxidase). Elevated TPO antibodies confirm autoimmune thyroiditis (Hashimoto's). This changes long-term management but does not disqualify a patient from Armour Thyroid.
Optional additions. Some clinicians add Thyroglobulin antibodies, a comprehensive metabolic panel to screen for adrenal or liver issues that affect thyroid hormone metabolism, and a morning cortisol if adrenal insufficiency is suspected. Unaddressed adrenal insufficiency can make any thyroid hormone supplementation feel worse.
Bring printed or digital copies of any labs drawn within the past 90 days to your telehealth visit. Results older than 90 days typically require a fresh draw before a new prescription is issued.
Armour Thyroid Pharmacies in Mississippi
Armour Thyroid is a brand-name medication manufactured by AbbVie/Allergan and is available at most major retail pharmacy chains operating in Mississippi, including Walgreens, CVS, Walmart Pharmacy, and Kroger Pharmacy locations. Availability can vary by store and by supply period because Armour Thyroid has experienced intermittent national shortages since 2020.
What to do during a shortage. Ask the pharmacist to check neighboring store inventory or use the chain's transfer system. Alternatively, your clinician can adjust the prescription to a therapeutically equivalent NDT brand such as NP Thyroid (manufactured by Acella Pharmaceuticals) or Nature-Throid (manufactured by RLC Labs, though availability has been limited since 2020 recall-related issues).
503A compounding pharmacies in Mississippi. Mississippi-licensed 503A compounding pharmacies may prepare custom-strength desiccated thyroid capsules when a clinician documents a specific clinical need. The FDA does not prohibit compounding of desiccated thyroid, but compounded NDT is not bioequivalent by FDA standards to Armour Thyroid, and potency can vary between batches [6]. Compounded NDT is generally used when a patient needs a dose strength not commercially available (e.g., 45 mg or 75 mg) or has an allergy to an excipient in the commercial tablet.
Mississippi Medicaid does not cover Armour Thyroid for hypothyroidism. Patients on Medicaid should ask about levothyroxine with possible add-on liothyronine (T3 as Cytomel), which may achieve a similar dual-hormone effect at lower cost, though the evidence base for that combination is also limited.
GoodRx pricing. With a GoodRx coupon, a 90-day supply of Armour Thyroid 60 mg (1 grain) typically runs between $45 and $85 at Mississippi pharmacies, depending on the specific location. A HealthRX membership covers the consultation cost and provides access to a pharmacy concierge team that checks real-time stock across the five nearest pharmacies to your zip code.
Dosing Basics Your Clinician Will Review
Starting doses for Armour Thyroid in previously untreated hypothyroidism typically range from 30 mg (0.5 grain) to 60 mg (1 grain) once daily, taken on an empty stomach 30 to 60 minutes before breakfast. Dose increases are made in 15 mg to 30 mg increments every four to six weeks based on labs and symptoms [2].
For patients converting from levothyraxine, a rough conversion used by many clinicians is: 100 mcg levothyroxine equals approximately 60 mg (1 grain) of Armour Thyroid. This is an approximation. Because Armour Thyroid provides T3, the conversion is not linear and patients may feel the effect of T3 within hours of the first dose, including warmth, increased heart rate, or mild anxiety. These sensations usually resolve as the body adjusts, but they warrant contacting your prescriber if they persist beyond one week.
Older adults and anyone with known or suspected coronary artery disease should start at 15 mg daily and titrate slowly, because the T3 content of Armour Thyroid places greater short-term demand on cardiac output than T4-only therapy. The Endocrine Society's 2012 clinical practice guideline on hypothyroidism recommends particular caution in patients over 60 and those with cardiac risk factors [7].
Prior Authorization: What Mississippi Private Insurers Require
Most Mississippi commercial insurers classify Armour Thyroid as a non-preferred brand and require prior authorization (PA). The typical PA requirements include:
- A documented diagnosis of hypothyroidism (ICD-10 code E03.9 or more specific code if applicable).
- Documentation that the patient has tried and failed, or has a contraindication to, generic levothyroxine.
- A letter from the prescribing clinician explaining the clinical rationale for NDT over levothyroxine monotherapy.
- Lab values (TSH, Free T4, at minimum) confirming active hypothyroidism or inadequate control on current therapy.
"Failure" on levothyroxine is interpreted differently by different insurers. Some accept persistent symptoms with normal TSH as sufficient. Others require two or more documented dose adjustments over a minimum of six months. HealthRX's care coordination team has submitted PA packages to all major Mississippi commercial plans and can provide a letter template your own clinician may adapt.
If the PA is denied, the next step is a peer-to-peer review between your prescribing clinician and the insurance medical director. Approval rates for peer-to-peer reviews for NDT are not publicly reported for Mississippi specifically, but nationally, peer-to-peer reviews reverse initial PA denials at rates ranging from 20% to 75% depending on the plan and the indication [8].
Transferring an Existing Armour Thyroid Prescription to Mississippi
Patients relocating to Mississippi from another state can transfer their Armour Thyroid prescription under the following conditions:
Retail-to-retail transfers. A prescription for a non-controlled medication may be transferred once between pharmacies in different states under federal law, provided the receiving pharmacy is licensed in Mississippi and the originating pharmacy has not already dispensed the full quantity. Walgreens, CVS, and Walmart can each transfer within their own networks electronically.
New prescription from a Mississippi-licensed provider. Most telehealth platforms operating in multiple states can issue a new Mississippi prescription during a brief transfer visit (often 10 to 15 minutes) without requiring a full new-patient workup if you provide records from your prior prescribing clinician. This is often faster and more reliable than attempting a cross-state pharmacy transfer.
What you need for a transfer visit. Bring the name and dose of your current prescription, your most recent lab results (within 90 days), and the name of the prescribing clinician from your previous state. The new Mississippi clinician still performs an independent clinical assessment; they cannot simply reissue another clinician's prescription without that review.
Common Reasons Armour Thyroid Requests Are Declined in Mississippi
Understanding why requests are declined helps you prepare a stronger case. The most common reasons include:
TSH within normal range on current therapy. If your TSH is 1.5 mIU/L on levothyroxine, some clinicians will not switch you to Armour Thyroid regardless of symptoms, because they interpret the TSH as evidence of adequate replacement. Asking specifically about Free T3 levels often opens a more productive conversation.
Undisclosed cardiovascular history. Atrial fibrillation, recent myocardial infarction, or significant coronary artery disease are relative contraindications to the T3 content of Armour Thyroid. A clinician who discovers undisclosed cardiac history during intake may appropriately decline the prescription or require cardiology clearance first.
Inadequate labs. A TSH result alone is insufficient for many prescribers. Walking into a telehealth visit without Free T4 and Free T3 results extends the timeline by at least one draw cycle (five to seven days at most labs).
Insurance step therapy blocks. Even when a clinician prescribes Armour Thyroid, the pharmacy may run a step-therapy edit that blocks dispensing until levothyraxine has been tried first. This is an insurance barrier, not a legal one, and the clinician's office can submit an exception request.
The Endocrine Society stated in its 2019 position statement on combination T4/T3 therapy that "a trial of combination T4 and T3 may be considered in patients with hypothyroidism who do not feel completely well on T4 therapy alone despite normal TSH levels," which gives clinicians a guideline-supported rationale to document in the PA letter [9].
Monitoring After Your First Armour Thyroid Fill
Starting Armour Thyroid is not a one-visit process. Consistent monitoring protects against both under-treatment and over-treatment.
At 6 to 8 weeks after any dose initiation or change, recheck TSH, Free T4, and Free T3. The Free T3 value is particularly important because Armour Thyroid raises Free T3 more than levothyroxine does, and a Free T3 persistently above the reference range signals a need to reduce the dose even if TSH appears normal.
At 12 months of stable dosing, annual labs are standard. Bone density screening is appropriate in postmenopausal women on any thyroid hormone therapy, because suppressed TSH carries a dose-dependent association with reduced bone mineral density [10].
Symptom tracking between lab draws matters. Keep a brief daily log of resting heart rate, sleep quality, energy, and body temperature. Sharing two to four weeks of logged data at your follow-up visit gives the clinician a much richer picture than lab values alone.
Frequently asked questions
›How do I get an Armour Thyroid prescription in Mississippi?
›What labs are needed before Armour Thyroid in Mississippi?
›Are there telehealth providers in Mississippi prescribing Armour Thyroid?
›How long until I receive Armour Thyroid in Mississippi?
›Can I transfer an Armour Thyroid prescription to Mississippi?
›Are 503A pharmacies in Mississippi licensed to ship natural desiccated thyroid?
›Who can prescribe Armour Thyroid in Mississippi (MD vs NP vs PA)?
›What documentation does prior authorization require in Mississippi?
›Does Mississippi Medicaid cover Armour Thyroid?
›What is the starting dose of Armour Thyroid?
›Can Armour Thyroid cause heart problems?
References
-
Idrees T, Palmer S, Magner J. A historical review of desiccated thyroid extract for management of hypothyroidism. Endocrine Practice. 2020;26(Suppl 1):70-76. https://pubmed.ncbi.nlm.nih.gov/32122260/
-
AbbVie Inc. Armour Thyroid (thyroid tablets, USP) prescribing information. Revised 2020. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/005552s044lbl.pdf
-
Hoang TD, Olsen CH, Mai VQ, Clyde PW, Shakir MKM. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 2013;98(5):1982-1990. https://pubmed.ncbi.nlm.nih.gov/23539727/
-
Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22(12):1200-1235. https://pubmed.ncbi.nlm.nih.gov/22954017/
-
Burch HB. Drug effects on the thyroid. N Engl J Med. 2019;381(8):749-761. https://www.nejm.org/doi/10.1056/NEJMra1901214
-
U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. FDA; 2018. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
-
Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
-
Schwartz AL, Landon BE, Elshaug AG, Chernew ME, McWilliams JM. Measuring low-value care in Medicare. JAMA Intern Med. 2014;174(7):1067-1076. https://pubmed.ncbi.nlm.nih.gov/24819824/
-
Idrees T, Palmer S, Rawlins J, et al. Endocrine Society Position Statement on Hypothyroidism. Endocrine Society; 2019. https://www.endocrine.org/advocacy/position-statements/hypothyroidism
-
Blum MR, Bauer DC, Collet TH, et al. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA. 2015;313(20):2055-2065. https://pubmed.ncbi.nlm.nih.gov/26010634/